Stephen Porter is Director of UCL Eastman Dental Institute where he has been Professor of Oral Medicine since 1997.
Porter is Professor of Oral Medicine and Head of the Division of Maxillofacial Medical Diagnostic & Surgical Sciences at UCL Eastman Dental Institute.
[1] Porter's research has focused on identifying diagnosing and preventing pre-cancer and cancer of the mouth and establishing treatments that lessen the adverse effects of cancer therapy.
His research has reported several firsts including: reporting the impact of AIDS and HIV disease on the mouth,[5] discovering the immunogenetic basis of aggressive periodontitis, reporting the viral cause of Kaposi's sarcoma (HHIV-8) in the mouth of some immune deficient patients[6] and describing the oral disease and the impact on oral health of scleroderma.
[7] He has worked with a host of patient groups to improve oral health and access to dental treatment for children and adults with complex medical problems, including SRUK, Lupus UK[8] and Ehlers-Danlos Support UK.